Generic Zomig Launches

Released: 05/20/2013   By: Mike Partridge, RPh

On May 14, 2013, Global Pharmaceuticals launched the Authorized Generic (AG) for Zomig and Zomig-ZMT (zolmitriptan and zolmitriptan ODT), Impax Pharma’s branded product. Annual U.S. brand sales for both products combined is $200M.

Zomig and Zomig-ZMT are indicated for the acute treatment of migraine with or without aura in adults, where a clear diagnosis of migraine has been established.